Evotec SE (EVOTF) Capital Expenditures (2021 - 2026)
Evotec SE's (EVOTF) quarterly Capital Expenditures came in at -$4873.8 in Q1 2026, up 74.54% year-on-year from -$2792.4 in Q1 2025, and down 100.01% quarter-over-quarter from $84.5 million in Q4 2025.
Evotec SE (EVOTF) Capital Expenditures (2021 - 2026) Analysis & Trends
Evotec SE has disclosed Capital Expenditures across 6 years of filings, most recently posting -$4873.8 for Q1 2026.
- Capital Expenditures for Q1 2026 came in at -$4873.8, up 74.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.5 million (down 32.73% YoY), and the FY2025 annual result was $84.4 million, down 32.73% from the prior year.
- Capital Expenditures came in at -$4873.8 for Q1 2026 at Evotec SE, down from $84.5 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $229.7 million in Q4 2023 to a low of -$160225.4 in Q2 2023.
- The 5-year median for Capital Expenditures is -$22004.2 (2025), against an average of $36.7 million.
- Peak annual rise in Capital Expenditures reached 638.8% in 2022, while the deepest fall reached 109924.74% in 2022.
- Evotec SE's Capital Expenditures stood at $184.9 million in 2022, then rose by 24.24% to $229.7 million in 2023, then tumbled by 45.3% to $125.6 million in 2024, then sank by 32.73% to $84.5 million in 2025, then sank by 100.01% to -$4873.8 in 2026.
- The last three Capital Expenditures figures came in at -$4873.8 (Q1 2026), $84.5 million (Q4 2025), and -$23625.4 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Evotec SE | - | - | - | -4,873.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,873.81 |
| Mar 31, 2026 | -4,873.81 |
| Dec 31, 2025 | 84.51 Mn |
| Dec 31, 2025 | 84.51 Mn |
| Sep 30, 2025 | -23,625.43 |
| Sep 30, 2025 | -23,625.43 |
| Jun 30, 2025 | -22,004.16 |
| Jun 30, 2025 | -22,004.16 |
| Mar 31, 2025 | -19,142.19 |
| Mar 31, 2025 | -19,142.19 |
| Dec 31, 2024 | 125.64 Mn |
| Dec 31, 2024 | 125.64 Mn |
| Sep 30, 2024 | -29,405.93 |
| Sep 30, 2024 | -29,405.93 |
| Jun 30, 2024 | -37,963.52 |
| Jun 30, 2024 | -37,963.52 |
| Mar 31, 2024 | -43,711.94 |
| Mar 31, 2024 | -43,711.94 |
| Dec 31, 2023 | 229.68 Mn |
| Dec 31, 2023 | 229.68 Mn |